Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PAVE (Parallactic Visual-Field Enhancement) System for Treatment of Chronic Visual Field Loss

NCT07185971 is registered in ClinicalTrials.gov with NeuroAEye LLC as lead sponsor.

NCT NCT07185971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07185971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PAVE (Parallactic Visual-Field Enhancement) System for Treatment of Chronic Visual Field Loss
Lead sponsor
NeuroAEye LLC
Phase
Not applicable
Overall status
Recruiting
Start date
March 16, 2026
Completion date
August 31, 2026
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

homonymous hemianopsia, homonymous quadrantanopia